Browse wiki

ANSI/ANS 15.8-1995 +, ANSI/ANS 15.8 +  and ANSI/ANS-5.8-1995 +

Atomic Energy Act of 1954 +, Endangered Species Act +, National Environmental Policy Act of 1969 +  and Clean Air Act +

Federal Energy Regulatory Commission +  and Environmental Protection Agency +

Uranium +, Lead +  and Plutonium +

10 CFR 20 +, 10 CFR 100 +, 10 CFR 50 +, 10 CFR 70 +, 10 CFR 70.61 +, 10 CFR 50.2 +, 10 CFR 51 +, 10 CFR 2.390 +, 10 CFR 50.22 +, 10 CFR 50.33 +, 10 CFR 50.35 +, 10 CFR 50.37 +, 10 CFR 50.40 +, 10 CFR 50.50 +, 10 CFR 50.58 +, 10 CFR 51.20 +, 10 CFR 51.29 +, 10 CFR 170.21 +, 10 CFR 70.23a +, 10 CFR 70.23 +, 10 CFR 51.105 +, 10 CFR 50.34#a +, 10 CFR 50.34#a1 +, 10 CFR 50.34#a5 +, 10 CFR 50.34#a7 +, 10 CFR 70.23#a7 +, 10 CFR 70.21#f +, 10 CFR 2.101#a5 +, 10 CFR 51.20#b7 +, 10 CFR 51.20#a2 +...

SECY-15-0088 +, SECY-012 +  and SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +

ML16344A049 +, ML042430055 +, ML042430048 +, ML062190191 +, ML17093A661 +, ML16056A122 +, ML17128A065 +, ML16236A013 +, ML17069A408 +, ML17013A584 +, ML15210A182 +, ML12156A069 +, ML16123A119 +, ML17130A862 +, ML17262A111 +, ML17283A108 +, ML17265A048 +, ML17283A109 +, ML14349A501 +, ML16305A029 +, ML15086A261 +, ML15238B093 +, ML15176A258 +, ML17313A100 +, ML17313A338 +, ML17257A019 +, ML17128A053 +, ML17310B511 +, ML17312A989 +, ML17313A978 +...

82 FR 22858 +, 80 FR 22227 +, 80 FR 32418 +, 46 FR 18026 +, 80 FR 72115 +, 81 FR 78865 +, 78 FR 63501 +, 81 FR 32793 +  and 80 FR 68880 +

Mccree V +  and NRC/EDO +

SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +, SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +, SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +, SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +, SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +, SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +, SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +, SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +, SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +, SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +, SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +, SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +, SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +  and SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +

Mo-99 +  and U-235 +

NUREG-2209, Availability of the NRCs Final EIS for the Northwest Medical Isotope Production Facility +, NUREG-0849, Informs That General Atomics Radiological Contingency Plan for Training & Familiarization Onsite for Offsite Response Organizations Acceptable & Approved by Nrc.Changes Were Revised Using NUREG-0849 +  and NUREG-1520, Recommends That 980504 Avlis Licensing Process License Application Be One Document W/O Part I/Part II Distinction. Staff Recommended Example of Application & Environ Rept Format,Encl +

SECY-15-0088 +, SECY-012 +  and SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility +

Missouri +, Oregon +  and Delaware +

Commissioners +  and NRC/OCM +

Loss of Offsite Power +, Exemption Request +, Uranium Hexafluoride +  and Spill +